en

PRODUCT DETAIL

Atorvastatín/Ezetimib Teva 20 mg/10 mg

Code 0465E
MA number 31/0097/22-S
Product Form: tbl flm 84x1x20 mg/10 mg (blis.OPA/Al/PVC/Al-jednotliv.dáv.)
MA Status: R - Valid Marketing Authorisation
Type of procedure: Mutual recognition procedure
Therapeutic Class: 31 - HYPOLIPIDAEMICA
ATC:
C CARDIOVASCULAR SYSTEM
C10 Lipid modifying agents
C10B Lipid modifying agents, combinations
C10BA Combinations of various lipid modifying agents
C10BA05 Atorvastatin and ezetimibe
Shelf life: 24
Container: blister OPA/Al/PVC/Al
Route of admin.: Oral use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 10b fixed combination application
MA issued: 29.04.2022
Validity: 29.04.2027
PIL: PIL_Atorvastatín-Ezetimib Teva_01.2024.pdf  
SPC: SPC_Atorvastatín-Ezetimib Teva_06.2023.pdf  
Safety feature Yes
Data update: 03.05.2022
eu-flag.png sk-flag.png